(2)(a) The board shall adopt rules to establish, in consultation with the Oregon Medical Board, the Oregon State Board of Nursing and the Oregon Health Authority, and in consideration of guidelines established by the American College of Obstetricians and Gynecologists or its successor organization, standard procedures for the prescribing of injectable hormonal contraceptives and self-administered hormonal contraceptives by pharmacists.
(b) The rules adopted under this subsection must require a pharmacist to:
(A) Complete a training program approved by the State Board of Pharmacy that is related to prescribing injectable hormonal contraceptives and self-administered hormonal contraceptives;
(B) Provide a self-screening risk assessment tool that the patient must use prior to the pharmacist’s prescribing the injectable hormonal contraceptive or self-administered hormonal contraceptive;
(C) Refer the patient to the patient’s primary care practitioner or women’s health care practitioner upon prescribing and administering the injectable hormonal contraceptive or prescribing and dispensing the self-administered hormonal contraceptive;
(D) Provide the patient with a written record of the injectable hormonal contraceptive prescribed and administered or the self-administered hormonal contraceptive prescribed and dispensed and advise the patient to consult with a primary care practitioner or women’s health care practitioner; and
(E) Administer the injectable hormonal contraceptive or dispense the self-administered hormonal contraceptive to the patient as soon as practicable after the pharmacist issues the prescription.
(c) The rules adopted under this subsection must prohibit a pharmacist from:
(A) Requiring a patient to schedule an appointment with the pharmacist for the prescribing or administering of an injectable hormonal contraceptive or the prescribing or dispensing of a self-administered hormonal contraceptive; and
(B) Prescribing and administering an injectable hormonal contraceptive or prescribing and dispensing a self-administered hormonal contraceptive to a patient who does not have evidence of a clinical visit for women’s health within the three years immediately following the initial prescription and administration of an injectable hormonal contraceptive or the initial prescription and dispensation of a self-administered hormonal contraceptive by a pharmacist to the patient.
(3) All state and federal laws governing insurance coverage of contraceptive drugs, devices, products and services apply to injectable hormonal contraceptives and self-administered hormonal contraceptives prescribed by a pharmacist under this section. [Formerly 689.683; 2019 c.13 §§65,66]
Structure 2021 Oregon Revised Statutes
Chapter 689 - Pharmacists; Drug Outlets; Drug Sales
Section 689.005 - Definitions.
Section 689.025 - Policy; purpose.
Section 689.045 - Severability.
Section 689.115 - Membership; qualifications; term; vacancy; compensation.
Section 689.135 - General powers of board; fees.
Section 689.151 - Board control over licensing, standards and discipline.
Section 689.155 - Authority of board over medications, drugs, devices and other materials; rules.
Section 689.165 - Officers; executive director.
Section 689.175 - Compensation of board members and executive director.
Section 689.207 - Authority of board to require fingerprints.
Section 689.255 - Qualifications for licensure by examination.
Section 689.265 - Qualifications for licensure by reciprocity.
Section 689.275 - Renewal of licenses; rules; fees.
Section 689.285 - Continuing education; rules; fees.
Section 689.305 - Registration of drug outlets; rules.
Section 689.315 - Application; rules.
Section 689.325 - Required reports.
Section 689.335 - Certificate required; reinstatement.
Section 689.405 - Grounds for discipline; investigation; procedure as contested case.
Section 689.445 - Penalties and reinstatement.
Section 689.490 - Board to establish licensing system; rules; fees.
Section 689.495 - Provision of licensing information.
Section 689.497 - Report required upon termination of pharmacy technician.
Section 689.499 - Pharmacy technician specialized education program; rules.
Section 689.503 - Licensing of pharmaceutical representatives; civil penalty; rules.
Section 689.505 - Labeling requirements; rules.
Section 689.515 - Regulation of generic drugs; substitutions; rules.
Section 689.522 - Substitution of biological products for prescribed biological products; rules.
Section 689.524 - Approval of coverage for biological product.
Section 689.525 - Out-of-state prescriptions.
Section 689.527 - Prohibited practices; rules.
Section 689.555 - Agricultural drugs and certain other substances.
Section 689.561 - Prescription readers; compatible labels; exception; rules.
Section 689.615 - Display of certificate or license; rules.
Section 689.645 - Vaccines, patient care services, drugs and devices; formulary; rules.
Section 689.649 - Public Health and Pharmacy Formulary Advisory Committee.
Section 689.655 - Power to administer drugs and devices; rules.
Section 689.661 - Power to perform tests and examinations related to federally cleared analytes.
Section 689.681 - Opiate overdose; treatments; administration of naloxone; rules.
Section 689.682 - Prescription of naloxone.
Section 689.684 - Administration of naloxone by certain persons; rules.
Section 689.686 - Notice of availability of naloxone; rules.
Section 689.692 - Dispensation of prescription drug containing cannabinoids; rules.
Section 689.700 - Telepharmacy; requirements; rules.
Section 689.704 - Preexposure and post-exposure antiretroviral therapies; HIV tests; rules.
Section 689.770 - Definitions for ORS 689.770 to 689.780.
Section 689.772 - Establishment of program; immunity from liability; rules; fee.
Section 689.776 - Inspection; audit.
Section 689.778 - Eligibility.
Section 689.832 - Civil penalties.
Section 689.854 - Civil penalty for violation of ORS 689.515.